News & Analysis on Clinical Trial Services & Contract Research And Development
Biotech contract manufacturer Diosynth and PDL Biopharma have extended their agreement for the commercial supply of PDL's heart attack treatment Retavase (reteplase), a move that signals the end of manufacturing issues PDL experienced with the drug.
A new international agreement will eliminate customs duties on pharmaceuticals and chemical intermediates traded between the major nations dealing in the industry. The move is set to save EU pharmaceutical companies around €230m in 2007.
Sanofi-Aventis has announced promising clinical trial data for a new antidepressant drug that works in a different way to others currently available.
Bio-Imaging Technologies has bought French imaging firm Theralys as it strives to broaden its clinical trial medical imaging service offerings.
The International Society for Pharmaceutical Engineering (ISPE) has released its latest industry guide, covering the commissioning and qualification of pharmaceutical water and steam systems.
Scientists have shown it is possible to mimic the complex stable structure of natural proteins using a different type of amino acid building block, potentially opening the door to more effective, longer-lasting biologic drugs.
The new Metabolomics system from ESA promises to speed up biomarker discovery and reduce the overwhelming amounts of data often associated with these studies.
ThromboGenics and Bioinvent's new anticoagulant antibody therapy that could last a month with just one dose has entered Phase I trials.
Albany Molecular Research (AMRI) has slipped again in the fourth quarter of 2006 recording an operating loss of $2.5m (€1.9m) - six per cent worse than the same quarter the previous year - despite encouraging revenue growth in its contract business.
Novartis, Kendle, Cambrex, Chiltern, Parexel and SRI International have all had people on the move in the world of pharmaceutical outsourcing.